Like I said earlier today, this is a buyout from a strategic buyer. This is not a liquidation of individual assets, not a joint venture (that would have been a financial buyer, there were none this round, no one wanted management from the KERP agreement), and BioAmber will be gone.
I am holding and hoping that the strategic buyer's bids are enough to give me some money out of this. The sale range is anywhere from 70 to 200 million for the whole pot. With the Assets almost double liabilities, and a one of kind plant, it's very likely.
